Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.
Options
BORIS DOI
Publisher DOI
PubMed ID
39455896
Date of Publication
2025-01
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Angelillo, Piera | |
Alarcon Tomas, Ana | |
Campodonico, Edoardo | |
Gabellier, Ludovic | |
Blau, Igor Wolfgang | |
Kwon, Mi | |
Ram, Ron | |
Forcade, Edouard | |
Besley, Caroline | |
Vucinic, Vladan | |
Kröger, Nicolaus | |
Corral, Lucía López | |
Vydra, Jan | |
Ferrari, Silvia | |
von Tresckow, Bastian | |
Rubio, Marie Therese | |
Hernani, Rafael | |
Sica, Simona | |
Stölzel, Friedrich | |
Rovira, Montserrat | |
Wagner-Drouet, Eva | |
Pérez-Simón, Jose Antonio | |
Castilla-Llorente, Cristina | |
Ferreri, Andres J M | |
Hoogenboom, Jorinde D | |
Sanchez Ortega, Isabel | |
Malard, Florent | |
Kuball, Jürgen | |
Ruggeri, Annalisa |
Additional Credits
Series
Bone Marrow Transplantation
Publisher
Springer Nature [academic journals on nature.com]
ISSN
1476-5365
0268-3369
Access(Rights)
restricted